Past Coverage of ACR 2015Past Coverage of ACR 2015 Return To RheumReports Home
Six Common Errors in Evaluating for Relapse in ANCA Associated Vasculitis
November 9 2015 6:37 PM ET — via RheumReports
This morning Dr. Peter Merkel presented a wonderful talk on ANCA Associated Vasculitis (AAV). He identified the following six errors when evaluating for relapse in AAV.
Assuming symptoms are due to AAV
Assuming rise in creatinine is due to AAV
Treating the ANCA titre or ESR/CRP. On the whole, there is currently no clear evidence that treating an isolated increase in ANCA is beneficial to patient outcomes.
Not considering new/changing co-morbidities. Patients develop other medical issues and co-morbidities over time. The new neuropathy may be due to their diabetes and not vasculitis.
Not considering the effect of treatments. Don’t forget to consider the side effects that treatment may have.
The original diagnosis of AAV was wrong. Remember to reconsider the diagnosis when the clinical situation does not make sense.
Share This Report
About the Author
Dr. Andy Thompson
Dr. Andy Thompson is an Associate Professor at Western University and founder of Rheuminfo.com, Rheumtalks.com, and RheumReports.com.
View Full Bio